Dana Yaacov-Garbeli
Chief Financial Officer · Entera Bio Ltd.
Individual
- 2025
- Aug 7, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dana Yaacov-Garbeli files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Geno J. Germano - $56K in ENTX purchases and sales in the last 12 months
- Sean Ellis - $35K in ENTX purchases and sales in the last 12 months
- Miranda Jayne Toledano - $20K in ENTX purchases and sales in the last 12 months
- Steven D. Rubin - $19K in ENTX purchases and sales in the last 12 months
- Haya Taitel - $11K in ENTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dana Yaacov-Garbeli?
Dana Yaacov-Garbeli is a corporate insider, tracked as Chief Financial Officer of Entera Bio Ltd. (ENTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dana Yaacov-Garbeli submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
